SCHEMBL7112266

SCHEMBL7112266

COc1ccc(CC(SNC(=O)[C@@H](C)NC(=O)[C@@H]2CN(C(=O)OC(C)(C)C)CCS2)C2CCCCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.38
MMP1 P03956 5/20 0.37
MMP9 P14780 5/20 0.37
MMP13 P45452 4/20 0.37
YAP1 P46937 1/20 0.37
STS P08842 1/20 0.36
MMP3 P08254 4/20 0.36
MMP7 P09237 4/20 0.36
MMP8 P22894 3/20 0.36
MMP2 P08253 2/20 0.36
POLB P06746 2/20 0.36
TP53 P04637 1/20 0.35
PSMB8 P28062 1/20 0.35
PSMB5 P28074 1/20 0.35
PSMB10 P40306 1/20 0.35
PSMB2 P49721 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105628 0.83 MEN1 (0.45) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7110901 0.81 MEN1 (0.43) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7105591 0.81 MEN1 (0.43) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7110470 0.81 MEN1 (0.43) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7109634 0.80 EPHX2 (0.36) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7774665 0.78 MEN1 (0.43) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7107121 0.77 MMP13 (0.35) MEN1KMT2AMMP1MMP13YAP1
SCHEMBL7104098 0.77 EPHX2 (0.37) ALDH1A1GAAMMP13YAP1POLB
SCHEMBL7110085 0.76 USP21 (0.39) MEN1KMT2AALDH1A1LMNA
SCHEMBL7768814 0.75 CACNA1B (0.39) MEN1KMT2AALDH1A1GAAMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030013725-A1 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. 2003-01-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013725-A1 Amino acid derivatives CACNA1B, SCN1A, SCN2A MEN1 2633/4885KMT2A 1929/4885ALDH1A1 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.